Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-14

FDA Approved: NASAL ALLERGY — Supplemental Application (Kroger Company)

View source ↗

Summary

The FDA approved a supplemental application for the Kroger Company's NASAL ALLERGY product containing Triamcinolone Acetonide (ANDA078104).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASAL ALLERGY (Triamcinolone Acetonide)

Snippet

SUPPL AP for NASAL ALLERGY (TRIAMCINOLONE ACETONIDE)